Literature DB >> 3808613

The autoimmune nature of aqueous tear deficiency.

S C Pflugfelder, K R Wilhelmus, M S Osato, A Y Matoba, R L Font.   

Abstract

Twenty-two patients with aqueous tear deficiency (ATD) were examined for the presence of the following autoantibodies: immunofluorescent antinuclear antibody (ANA) and Sjögren's syndrome antibodies A and B (SS-A and SS-B). These autoantibodies were found in 17 (82%) patients but not in control subjects, and they correlated with the severity of symptoms and ocular surface changes. Bacterial keratitis, often recurrent and bilateral, and progressive sterile corneal stromal melting developed in six autoantibody-positive ATD patients. Eight antibody-positive patients had labial salivary or lacrimal gland biopsies, and all showed similar histologic features with marked destruction of the glandular architecture by lymphocytic infiltration. Immunoglobulin and complement were not detected in the glandular tissue. Circumstantial evidence suggests that an abnormal immunologic reaction, possibly related to Epstein-Barr viral (EBV) infection, is the cause of the glandular destruction and tear deficiency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3808613     DOI: 10.1016/s0161-6420(86)33528-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Distinct dacryoadenitides autoadoptively transferred to rabbits by different subpopulations of lymphocytes activated ex vivo.

Authors:  Padmaja B Thomas; Deedar M Samant; Yanru Wang; Shivaram Selvam; Douglas Stevenson; John D Gray; Joel E Schechter; Austin K Mircheff; Melvin D Trousdale
Journal:  Cornea       Date:  2010-10       Impact factor: 2.651

Review 2.  Biological functions of tear film.

Authors:  Stephen C Pflugfelder; Michael E Stern
Journal:  Exp Eye Res       Date:  2020-06-16       Impact factor: 3.467

3.  Retrovirus in salivary glands from patients with Sjögren's syndrome.

Authors:  S Yamano; J N Renard; F Mizuno; Y Narita; Y Uchida; H Higashiyama; H Sakurai; I Saito
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

4.  High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.

Authors:  Mohammad H Dastjerdi; Pedram Hamrah; Reza Dana
Journal:  Cornea       Date:  2009-12       Impact factor: 2.651

5.  Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.

Authors:  Ian S Zagon; Matthew S Klocek; Joseph W Sassani; Patricia J McLaughlin
Journal:  Arch Ophthalmol       Date:  2009-11

6.  Sjögren's syndrome: History, clinical and pathological features.

Authors:  A L Parke; W W Buchanan
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

Review 7.  Immune - Goblet cell interaction in the conjunctiva.

Authors:  Jehan Alam; Cintia S de Paiva; Stephen C Pflugfelder
Journal:  Ocul Surf       Date:  2020-01-14       Impact factor: 5.033

Review 8.  Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.

Authors:  Diane D-S Tang-Liu; Andrew Acheampong
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

Review 9.  Dry eye: diagnosis and current treatment strategies.

Authors:  Paul D O'Brien; Louis M T Collum
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

Review 10.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.